Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salutem Pharma is a privately held European pharmaceutical company focused on the development, marketing, distribution, regulatory support, and contract manufacturing of branded generic pharmaceuticals, food supplements, herbal products, and dermo-cosmetics. The company presents itself as operating through entities in Germany, Greece, and Austria, with its Berlin office serving as a visible group contact point and the Greek entity focused on producing and marketing branded generics in Europe and the MENA region. Salutem also offers third-party services spanning warehousing, import management, hospital deliveries, international distribution, regulatory affairs, GMP quality control, and contract manufacturing. Its commercial portfolio includes cardiovascular/metabolic, urology, respiratory, gastrointestinal, and anti-infective products, indicating that Salutem is a commercial-stage specialty generics and pharma services business rather than a clinical-stage biotech innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salutem Pharma.